Association For Innovation And Biomedical Research On Light And Image
Association For Innovation And Biomedical Research On Light And Image is recorded as a service provider in 8 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 8 of 8 trials · Latest update first
A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea High Dose (HD) in Participants with Diabetic Macular Edema (ALVOEYE-HD)
Sponsor Alvotech Swiss AG
- Start (EU)
- Latest update
- Estimated end
A dose-ranging randomized, open-label study evaluating the effect of bilateral intravitreal injection of GS010 at two dose levels on visual acuity and retinal mitochondrial activity in patients affected with ND4 Leber Hereditary Optic Neuropathy – The REVISE Study
Sponsor Gensight Biologics
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Sponsor Adarx Pharmaceuticals Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy (SEER-2)
Sponsor Regentree LLC
- Start (EU)
- Latest update
- Estimated end
A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects with Retinitis Pigmentosa.
Sponsor Gensight Biologics
- Start (EU)
- Latest update
- Estimated end
(22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion
Sponsor Bayer AG
- Start (EU)
- Latest update
- Estimated end
SEER-3: A Phase 3, Multi-Center, Randomized, Parallel, Double Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of Neurotrophic Keratopathy
Sponsor Regentree LLC
- Start (EU)
- Latest update
- Estimated end
- Not reported
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in the PDE6B Gene Leading to a Defect in PDE6ß Expression
Sponsor eyeDNA Therapeutics
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Association For Innovation And Biomedical Research On Light And Image?
The 2026-10-09 snapshot links Association For Innovation And Biomedical Research On Light And Image to 8 distinct CTIS trials. Recorded services include Medical expertise, Data management, Electronic data capture, Central reading, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Association For Innovation And Biomedical Research On Light And Image?
The most frequently recorded therapeutic areas are Ophthalmology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Association For Innovation And Biomedical Research On Light And Image conducted?
The linked trials record locations in 14 countries, including Spain, France, Italy, Poland, Germany. These are trial locations, not confirmed office locations or countries where Association For Innovation And Biomedical Research On Light And Image delivered services.
What can this page tell me about Association For Innovation And Biomedical Research On Light And Image's trial experience?
Browse 8 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Association For Innovation And Biomedical Research On Light And Image. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Association For Innovation And Biomedical Research On Light And Image